FDA — authorised 30 April 1998
- Application: NDA020896
- Marketing authorisation holder: CHEPLAPHARM
- Local brand name: XELODA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Capecitabine Oral Product in United States
FDA authorised Capecitabine Oral Product on 30 April 1998
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Capecitabine Oral Product approved in United States?
Yes. FDA authorised it on 30 April 1998.
Who is the marketing authorisation holder for Capecitabine Oral Product in United States?
CHEPLAPHARM holds the US marketing authorisation.